MINIMAL RESIDUAL DISEASE ASSESSED BY NPM1 MUTATION-SPECIFIC RQ-PCR ASSAYS HAS A PROGNOSTIC VALUE IN ACUTE MYELOID LEUKEMIA (AML) AND IS SIGNIFICANTLY DECREASED BY TREATMENT WITH GEMTUZUMAB OZOGAMICIN

被引：0
|
作者：
Lambert, J. [1 ,2 ]
Lambert, J. [1 ,2 ]
Nibourel, O. [3 ]
Pautas, C. [4 ]
Hayette, S. [5 ]
Cayuela, J. M. [6 ]
Terre, C. [7 ]
Dombret, H. [8 ]
Preudhomme, C. [3 ]
Castaigne, S. [9 ]
Renneville, A. [3 ]
机构：
[1] Univ Versailles St Quentin, Hop Versailles, Le Chesnay, France
[2] Hop St Louis, Serv Biostat & Informat Med, Paris, France
[3] CHRU Lille, Lab Hematol, Lille, France
[4] Hop Henri Mondor, Serv Hematol Clin, Creteil, France
[5] CH Lyon Sud, Lab Hematol, Pierre Benite, France
[6] Hop St Louis, Lab Hematol, Paris, France
[7] Ctr Hosp Versailles, Lab Cytogenet, Le Chesnay, France
[8] Hop St Louis, Serv Hematol Adulte, Paris, France
[9] Ctr Hosp Versailles, Serv Hematol & Oncol, Le Chesnay, France
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0537
引用
收藏
页码：215 / 216
页数：2
相关论文
共 40 条
  • [1] Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
    Schnittger, Susanne
    Kern, Wolfgang
    Tschulik, Claudia
    Weiss, Tamara
    Dicker, Frank
    Falini, Brunangelo
    Haferlach, Claudia
    Haferlach, Torsten
    BLOOD, 2009, 114 (11) : 2220 - 2231
  • [2] Minimal Residual Disease Assessed by NPM1 Mutation Specific RQ-PCR Is the Most Relevant Prognostic Parameter in NPM1-Mutated AML and Highly Useful to Guide Therapy
    Schnnittger, Susanne
    Kern, Wolfgang
    Weiss, Tamara
    Tschulik, Claudia
    Dicker, Frank
    Haferlach, Claudia
    Haferlach, Torsten
    BLOOD, 2008, 112 (11) : 260 - 260
  • [3] PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE MONITORING USING NPM1 MUTATION IN AML
    Itzykson, R. I.
    Boissel, N.
    Fenaux, P.
    Quesnel, B.
    Fernandes, J.
    Castaigne, S.
    Malfuson, J. V.
    Nguyen, S.
    Curtillet, C.
    Beaumont, M.
    Marolleau, J. P.
    Perel, Y.
    Caillot, D.
    Bertrand, Y.
    Glaisner, S.
    Pautas, C.
    Preudhomme, C.
    Renneville, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 109 - 109
  • [4] Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG)
    Kroenke, Jan
    Schlenk, Richard
    Jensen, Kai-Ole
    Eiwen, Karina
    Habdank, Marianne
    Spaeth, Daniela
    Krauter, Juergen
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2008, 112 (11) : 260 - 260
  • [5] Prognostic impact of minimal residual disease (MRD) assessment in acute myeloid leukemia (AML) with mutated NPM1: Results of the AML study group (AMLSG)
    Kroenke, J.
    Schlenk, R. F.
    Jensen, K-O
    Eiwen, K.
    Onken, S.
    Habdank, M.
    Spaeth, D.
    Krauter, J.
    Ganser, A.
    Goehring, G.
    Schlegelberger, B.
    Luebbert, M.
    Wattad, M.
    Kindler, T.
    Salih, H. R.
    Mergenthaler, H-G
    Goetze, K.
    Doehner, H.
    Doehner, K.
    ONKOLOGIE, 2010, 33 : 136 - 136
  • [6] Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
    Mencia-Trinchant, Nuria
    Hu, Yang
    Alas, Maria Antonina
    Ali, Fatima
    Wouters, Bas J.
    Lee, Sangmin
    Ritchie, Ellen K.
    Desai, Pinkal
    Guzman, Monica L.
    Roboz, Gail J.
    Hassane, Duane C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (04): : 537 - 548
  • [7] c-MYC stain as a potential minimal residual disease marker for acute myeloid leukemia with NPM1 mutation
    Lyapichev, Kirill A.
    Behdad, Amir
    BLOOD, 2025, 145 (05) : 547 - 547
  • [8] Immunophenotypic Abnormalities in Acute Myeloid Leukemia Associated with NPM1 Mutation and Clinical Significance of Minimal Residual Disease Detection
    Zhou, Yi
    Wu, David
    Chen, Xueyan
    Fromm, Jonathan R.
    Wood, Brent L.
    MODERN PATHOLOGY, 2016, 29 : 387A - 388A
  • [9] Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with normal karyotype carrying NPM1 gene mutations
    Agueli, C.
    La Rosa, M.
    Fabbiano, F.
    Rizzo, V
    Cascio, L.
    Cammarata, G.
    Marfia, A.
    Bica, M. G.
    Mirto, S.
    Santoro, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 169 - 169
  • [10] Immunophenotypic Abnormalities in Acute Myeloid Leukemia Associated with NPM1 Mutation and Clinical Significance of Minimal Residual Disease Detection
    Zhou, Yi
    Wu, David
    Chen, Xueyan
    Fromm, Jonathan R.
    Wood, Brent L.
    LABORATORY INVESTIGATION, 2016, 96 : 387A - 388A
1234